{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:39:29Z","timestamp":1794069569195,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["2024HXBH029"],"award-info":[{"award-number":["2024HXBH029"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital of Sichuan University","doi-asserted-by":"publisher","award":["2023NSFSC1895"],"award-info":[{"award-number":["2023NSFSC1895"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["GZC20231836"],"award-info":[{"award-number":["GZC20231836"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1902"],"award-info":[{"award-number":["2024NSFSC1902"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.esmoop.2025.105551","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:07:58Z","timestamp":1755745678000},"page":"105551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Yu-Wen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Xia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Bing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jian","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.esmoop.2025.105551_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2017.0019","article-title":"Locally advanced colon cancer: evaluation of current clinical practice and treatment outcomes at the population level","volume":"15","author":"Klaver","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.esmoop.2025.105551_bib2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00384-021-03945-3","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis","volume":"36","author":"Gosavi","year":"2021","journal-title":"Int J Colorectal Dis"},{"issue":"23","key":"10.1016\/j.esmoop.2025.105551_bib3","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1200\/JCO.2010.32.5357","article-title":"Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581","volume":"29","author":"Niedzwiecki","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2025.105551_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113308","article-title":"Recurrence risk after radical colorectal cancer surgery-less than before, but how high is it?","volume":"12","author":"Osterman","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105551_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1463-1318.2011.02638.x","article-title":"Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience","volume":"14","author":"Dighe","year":"2012","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105551_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PAS.0000000000000518","article-title":"Perineural invasion is a strong prognostic factor in colorectal cancer: a systematic review","volume":"40","author":"Knijn","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105551_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1245\/s10434-014-3982-1","article-title":"Survival paradox between stage IIB\/C (T4N0) and stage IIIA (T1-2N1) colon cancer","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2025.105551_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10151-020-02289-4","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review","volume":"24","author":"Arredondo","year":"2020","journal-title":"Tech Coloproctol"},{"issue":"16","key":"10.1016\/j.esmoop.2025.105551_bib9","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105551_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clon.2015.11.003","article-title":"Neoadjuvant treatment strategies for locally advanced rectal cancer","volume":"28","author":"Gollins","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"17","key":"10.1016\/j.esmoop.2025.105551_bib11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"issue":"5s","key":"10.1016\/j.esmoop.2025.105551_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.6004\/jnccn.2018.0037","article-title":"Management of locoregional rectal cancer","volume":"16","author":"Willett","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"9319","key":"10.1016\/j.esmoop.2025.105551_bib13","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105551_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"9373","key":"10.1016\/j.esmoop.2025.105551_bib15","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(03)13580-5","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis","volume":"361","year":"2003","journal-title":"Lancet"},{"issue":"9666","key":"10.1016\/j.esmoop.2025.105551_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105551_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/DCR.0000000000001012","article-title":"Comparison of Western and Asian guidelines concerning the management of colon cancer","volume":"61","author":"Pellino","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"17","key":"10.1016\/j.esmoop.2025.105551_bib18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1403108","article-title":"Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer","volume":"371","author":"Loupakis","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105551_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105551_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105551_bib21","first-page":"881","article-title":"[New guidelines to evaluate the response to treatment in solid tumors]","volume":"87","author":"Duffaud","year":"2000","journal-title":"Bull Cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2025.105551_bib22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(12)70348-0","article-title":"Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105551_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.21147\/j.issn.1000-9604.2016.06.06","article-title":"A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer","volume":"28","author":"Zhou","year":"2016","journal-title":"Chin J Cancer Res"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105551_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.20.01330","article-title":"Duration of adjuvant doublet chemotherapy (3 or 6 months) in patients with high-risk stage II colorectal cancer","volume":"39","author":"Iveson","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105551_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/j.gastro.2012.06.001","article-title":"Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer","volume":"143","author":"Lieberman","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.esmoop.2025.105551_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejca.2019.01.006","article-title":"Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial","volume":"110","author":"Masi","year":"2019","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105551_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/DCR.0000000000002424","article-title":"Neoadjuvant modified FOLFOXIRI with selective radiotherapy in locally advanced rectal Cancer: long-term outcomes of phase II study and propensity-score-matched comparison with chemoradiotherapy","volume":"66","author":"Zhang","year":"2023","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.esmoop.2025.105551_bib28","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/codi.16116","article-title":"Neoadjuvant chemotherapy in patients undergoing colonic resection for locally advanced nonmetastatic colon cancer: a nationwide propensity score matched cohort study","volume":"24","author":"Laursen","year":"2022","journal-title":"Colorectal Dis"},{"issue":"10","key":"10.1016\/j.esmoop.2025.105551_bib29","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3109\/0284186X.2015.1037007","article-title":"Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial","volume":"54","author":"Jakobsen","year":"2015","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2025.105551_bib30","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.22.00046","article-title":"Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial","volume":"41","author":"Morton","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105551_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/SLA.0000000000003454","article-title":"Perioperative FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a phase II multicenter randomized controlled trial (PRODIGE 22)","volume":"271","author":"Karoui","year":"2020","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105551_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00280-007-0588-3","article-title":"Tritherapy with fluorouracil\/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases","volume":"62","author":"Ychou","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.esmoop.2025.105551_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2018.09.006","article-title":"FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: results of the FFCD 1102 phase II trial","volume":"104","author":"Bachet","year":"2018","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.esmoop.2025.105551_bib34","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1111\/j.1463-1318.2012.03079.x","article-title":"A nationwide study on anastomotic leakage after colonic cancer surgery","volume":"14","author":"Krarup","year":"2012","journal-title":"Colorectal Dis"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105551_bib35","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925014206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925014206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:59:47Z","timestamp":1772895587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925014206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2059702925014206"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105551","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"105551"}}